Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da FIOCRUZ (ARCA) |
Texto Completo: | https://www.arca.fiocruz.br/handle/icict/10578 |
Resumo: | Agence Nationale de Recherches sur le Sida et les Hépatites Virales |
id |
CRUZ_6e6582f140fc14d7943fca60d47b0dbb |
---|---|
oai_identifier_str |
oai:www.arca.fiocruz.br:icict/10578 |
network_acronym_str |
CRUZ |
network_name_str |
Repositório Institucional da FIOCRUZ (ARCA) |
repository_id_str |
2135 |
spelling |
Bhatt, Nilesh BalbhadraBarau, CarolineAmin, AlexandreBaudin, ElisabethMeggi, BindiyaSilva, CarlotaFurlan, ValerieGrinsztejn, BeatrizTran, Aurelie BarrailBonnet, MarylineTaburet, Anne Marie2015-05-28T17:04:16Z2015-05-28T17:04:16Z2014BHATT, Nilesh Balbhadra et al. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Antimicrobial Agents and Chemotherapy, v.58, n.6, p.3182–3190, 2014.0066-4804https://www.arca.fiocruz.br/handle/icict/1057810.1128/AAC.02379-131098-6596Agence Nationale de Recherches sur le Sida et les Hépatites ViralesFundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, Brasil / Ministério da Saúde. Instituto Nacional de Saúde. Maputo, MozambiqueBicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, FranceBicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, FranceEpicentre. Paris, PAR, FranceMinistério da Saúde. Instituto Nacional de Saúde. Maputo, MozambiqueEpicentre. Paris, PAR, FranceBicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, FranceFundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Rio de Janeiro, RJ, BrasilBicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, France / University Paris Sud. Faculty of Pharmacy. Paris, FranceEpicentre. Paris, PAR, FranceBicêtre Hospital. Assistance Publique Hôpitaux de Paris. Paris, PAR, France / Hôpitaux Universitaires Paris Sud. Clinical Pharmacy. Paris, PAR, FranceengAmerican Society for MicrobiologyPharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatmentinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleTuberculosisHIVRifampinIsoniazidTuberculoseHIVRifampinaIsoniazidainfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82352https://www.arca.fiocruz.br/bitstream/icict/10578/1/license.txtafbdf7d7a9bcf771a1cc7edf5f618413MD51ORIGINALPharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected.pdfPharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected.pdfapplication/pdf621835https://www.arca.fiocruz.br/bitstream/icict/10578/2/Pharmacokinetics%20of%20Rifampin%20and%20Isoniazid%20in%20Tuberculosis-HIVCoinfected.pdfcadfb184f2cb879bef44dd91bc027a8fMD52TEXTPharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected.pdf.txtPharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIVCoinfected.pdf.txtExtracted texttext/plain53606https://www.arca.fiocruz.br/bitstream/icict/10578/3/Pharmacokinetics%20of%20Rifampin%20and%20Isoniazid%20in%20Tuberculosis-HIVCoinfected.pdf.txt47c9c1efe31cc227787e1bee188497bbMD53icict/105782023-06-15 16:17:42.157oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-06-15T19:17:42Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.pt_BR.fl_str_mv |
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment |
title |
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment |
spellingShingle |
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment Bhatt, Nilesh Balbhadra Tuberculosis HIV Rifampin Isoniazid Tuberculose HIV Rifampina Isoniazida |
title_short |
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment |
title_full |
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment |
title_fullStr |
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment |
title_full_unstemmed |
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment |
title_sort |
Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment |
author |
Bhatt, Nilesh Balbhadra |
author_facet |
Bhatt, Nilesh Balbhadra Barau, Caroline Amin, Alexandre Baudin, Elisabeth Meggi, Bindiya Silva, Carlota Furlan, Valerie Grinsztejn, Beatriz Tran, Aurelie Barrail Bonnet, Maryline Taburet, Anne Marie |
author_role |
author |
author2 |
Barau, Caroline Amin, Alexandre Baudin, Elisabeth Meggi, Bindiya Silva, Carlota Furlan, Valerie Grinsztejn, Beatriz Tran, Aurelie Barrail Bonnet, Maryline Taburet, Anne Marie |
author2_role |
author author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Bhatt, Nilesh Balbhadra Barau, Caroline Amin, Alexandre Baudin, Elisabeth Meggi, Bindiya Silva, Carlota Furlan, Valerie Grinsztejn, Beatriz Tran, Aurelie Barrail Bonnet, Maryline Taburet, Anne Marie |
dc.subject.en.pt_BR.fl_str_mv |
Tuberculosis HIV Rifampin Isoniazid |
topic |
Tuberculosis HIV Rifampin Isoniazid Tuberculose HIV Rifampina Isoniazida |
dc.subject.decs.pt_BR.fl_str_mv |
Tuberculose HIV Rifampina Isoniazida |
description |
Agence Nationale de Recherches sur le Sida et les Hépatites Virales |
publishDate |
2014 |
dc.date.issued.fl_str_mv |
2014 |
dc.date.accessioned.fl_str_mv |
2015-05-28T17:04:16Z |
dc.date.available.fl_str_mv |
2015-05-28T17:04:16Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
BHATT, Nilesh Balbhadra et al. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Antimicrobial Agents and Chemotherapy, v.58, n.6, p.3182–3190, 2014. |
dc.identifier.uri.fl_str_mv |
https://www.arca.fiocruz.br/handle/icict/10578 |
dc.identifier.issn.none.fl_str_mv |
0066-4804 |
dc.identifier.doi.none.fl_str_mv |
10.1128/AAC.02379-13 |
dc.identifier.eissn.none.fl_str_mv |
1098-6596 |
identifier_str_mv |
BHATT, Nilesh Balbhadra et al. Pharmacokinetics of rifampin and isoniazid in tuberculosis-HIV-coinfected patients receiving nevirapine- or efavirenz-based antiretroviral treatment. Antimicrobial Agents and Chemotherapy, v.58, n.6, p.3182–3190, 2014. 0066-4804 10.1128/AAC.02379-13 1098-6596 |
url |
https://www.arca.fiocruz.br/handle/icict/10578 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
American Society for Microbiology |
publisher.none.fl_str_mv |
American Society for Microbiology |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Repositório Institucional da FIOCRUZ (ARCA) |
collection |
Repositório Institucional da FIOCRUZ (ARCA) |
bitstream.url.fl_str_mv |
https://www.arca.fiocruz.br/bitstream/icict/10578/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/10578/2/Pharmacokinetics%20of%20Rifampin%20and%20Isoniazid%20in%20Tuberculosis-HIVCoinfected.pdf https://www.arca.fiocruz.br/bitstream/icict/10578/3/Pharmacokinetics%20of%20Rifampin%20and%20Isoniazid%20in%20Tuberculosis-HIVCoinfected.pdf.txt |
bitstream.checksum.fl_str_mv |
afbdf7d7a9bcf771a1cc7edf5f618413 cadfb184f2cb879bef44dd91bc027a8f 47c9c1efe31cc227787e1bee188497bb |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
repositorio.arca@fiocruz.br |
_version_ |
1813009119754321920 |